MONDAY, April 16 (HealthDay News) — Omega-3 fatty acid
supplements don’t appear to have any benefit on multiple sclerosis (MS),
according a study by Norwegian researchers.
Multiple sclerosis affects about 2.5 million people worldwide. Some
prior research has indicated that omega-3 fatty acid supplements might
have anti-inflammatory effects that could benefit those with the disease,
according to background information in the study.
Omega-3 fatty acids are found in cold-water fish, such as salmon, and
in fish oil supplements.
“Our study provides evidence that omega-3 supplementation has no
beneficial effect on MS, neither given alone nor in combination with
interferon treatment,” said lead researcher Dr. Oivind Torkildsen, from
Haukeland University Hospital, in Bergen. Interferon is a standard drug
given to MS patients.
“Our data do not suggest that omega-3 fatty acid supplementation was
harmful or that it interfered with interferon beta treatment,” he added.
This study is important, not only for neurologists and MS patients, but
also for general practitioners, who frequently advise patients about
lifestyle interventions and complementary approaches to MS treatment,
Torkildsen said.
The report was published in the April 16 online edition of the
Archives of Neurology.
For the study, Torkildsen’s team looked at 92 MS patients, aged 18 to
55, with a form of the disease known as relapsing-remitting multiple
sclerosis.
Half of the patients were given the supplement alone or the supplement
plus injections of interferon beta-1a. The other half received an inactive
placebo.
After six months, all patients were given interferon beta-1a three
times a week for an additional 18 months.
When the patients underwent MRI brain scans to look for new lesions,
the researchers found no effect on the disease among those taking omega-3
fatty acid supplements.
The results were the same whether omega-3 fatty acid supplements were
used alone or in combination with interferon beta-1a, the study authors
noted.
These findings were in contrast with two other studies that showed
possible positive effects from fish oil supplements, Torkildsen and
colleagues pointed out.
No difference existed between the groups in the number of relapses
during the first six months of treatment or after 24 months, and there
were no differences in fatigue or quality of life, according to the
results.
Commenting on the study, Dr. Kottil Rammohan, a professor of neurology
and director of the MS division at the University of Miami Miller School
of Medicine, said, “It doesn’t surprise me that omega-3 fatty acids had no
effect on MS. I have never looked upon omega-3 fatty acids as having an
effect on MS and I have a lot of patients who take these supplements for
heart health,” he said.
However, Rammohan added, “This study won’t change my advice to patients
to take omega-3 fatty acid supplements because they have other health
benefits.”
More information
For more information on MS, visit the National
Multiple Sclerosis Society.
Related posts:
Views: 0